Alyeska Investment Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-238,412
| Closed | -$2.81M | – | 627 |
|
|
2021
Q4 | $2.81M | Sell |
238,412
-25,000
| -9% | -$294K | 0.03% | 389 |
|
|
2021
Q3 | $3M | Buy |
263,412
+13,795
| +6% | +$157K | 0.04% | 420 |
|
|
2021
Q2 | $3.48M | Buy |
249,617
+25,000
| +11% | +$348K | 0.04% | 414 |
|
|
2021
Q1 | $4.16M | Sell |
224,617
-93,501
| -29% | -$1.73M | 0.05% | 355 |
|
|
2020
Q4 | $5.62M | Sell |
318,118
-13,421
| -4% | -$237K | 0.08% | 248 |
|
|
2020
Q3 | $5.08M | Buy |
331,539
+259,062
| +357% | +$3.97M | 0.08% | 261 |
|
|
2020
Q2 | $1.85M | Buy |
+72,477
| New | +$1.85M | 0.03% | 349 |
|
|
2020
Q1 | – | Sell |
-387,427
| Closed | -$4.29M | – | 401 |
|
|
2019
Q4 | $4.29M | Buy |
387,427
+24,806
| +7% | +$274K | 0.06% | 228 |
|
|
2019
Q3 | $3.09M | Buy |
362,621
+150,000
| +71% | +$1.28M | 0.04% | 251 |
|
|
2019
Q2 | $2.88M | Buy |
212,621
+81,119
| +62% | +$1.1M | 0.04% | 271 |
|
|
2019
Q1 | $2.38M | Buy |
+131,502
| New | +$2.38M | 0.03% | 245 |
|
|
2018
Q3 | – | Sell |
-84,313
| Closed | -$1.46M | – | 423 |
|
|
2018
Q2 | $1.46M | Buy |
+84,313
| New | +$1.46M | 0.01% | 347 |
|